Information for institutional quotation
Bronchogen: price, documentation and dispatch in Colombia
Bronchogen is listed as a short peptide bioregulator for laboratory research. This page covers the listed 20 mg vial, current pricing and the documents to request for the batch.
Presentations and visible prices
| Presentation | Code | Reference price |
|---|---|---|
| 20mg | * | US$215 |
The price above is the public value per vial. Availability and batch documentation are confirmed before the quotation is accepted.
Bronchogen and the short peptide bioregulator family
Bronchogen belongs to the short peptide bioregulator family: minimal-chain synthetic peptides that the technical literature groups by a shared research origin, not by an action described on this page. The catalog does not publish the amino-acid sequence of Bronchogen or of any other reference in this family; what is stated is the general classification and the commercial presentation.
Bronchogen is grouped with Cardiogen, Cartalax, Cortagen, Crystagen, Pinealon and Vesugen. A shared catalog category does not make these products interchangeable. Each requires its own identity documentation.
Seven references, one origin: why the name matters
The catalog's short peptide bioregulator family brings together seven names: Bronchogen, Cardiogen, Cartalax, Cortagen, Crystagen, Pinealon, and Vesugen. All share the same general classification and a short-chain structure; none has a published sequence, CAS number, or purity figure on this site that distinguishes it from the others beyond its name and reference code.
That circumstance makes the exact name the single most important data point for an institutional purchase: requesting "Bronchogen" and receiving a vial with another name from the same family is not a minor error, even though both share a classification. The request, the quote, and the receiving record must use the same designation that appears on this page.
20 mg presentation and declared physical form
Bronchogen comes in 20 mg vials. Because it is a mass and not a volume in milliliters, its physical form is lyophilized powder in a vial, the same criterion the catalog applies to any presentation measured in milligrams. That physical form governs vial handling, not any subsequent use, which is outside the scope of this page.
The 20 mg presentation matches Cardiogen, Cartalax, and Cortagen within the same family; Pinealon is also offered in 5 and 10 mg, and Vesugen in 10 mg. Confirming the exact presentation on the quote avoids comparing prices across different presentations within the same group.
How to tell Bronchogen apart from its six peers when quoting
Bronchogen's price, like that of each of its six family peers, is shown as currently in force in this page's commercial block, and must be confirmed there before approving any quote, without assuming it matches another reference in the group.
The catalog can update those figures without prior notice, so the request, the quote, and the payment receipt must always repeat the exact name — Bronchogen — and not that of another family member, so the receiving record leaves no room for confusion.
Bronchogen's COA: Janoshik Analytical, HPLC, and mass spectrometry
The certificate of analysis (COA) for each lot of Bronchogen is issued by Janoshik Analytical. The report states purity by HPLC and identity by mass spectrometry (MS). This page does not publish a purity figure of its own for Bronchogen, because that data belongs to the report of the specific lot being shipped, not to the reference in general.
The COA is handled on request and subject to documentary availability. Upon receiving it, verify that the reference name — Bronchogen, not another member of the same family — and the lot identifier match the material delivered. Sequence, CAS number, and molecular weight are not filled in here: if a file requires them, they are requested separately and verified against a documentary source of the institution's own.
Lot storage and nationwide shipping
Bronchogen is stored according to the documentation applicable to the lot; if it specifies 2–8 °C and protection from light, those conditions are built into custody before shipping is received. Rates for shipping to Bogotá and to the rest of the country are shown on the site's shipping information, with times confirmed at the time of quote. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.
The order is registered first, the quote is confirmed in writing with presentation, price, and shipping, and payment is coordinated afterward through the method defined there. The purchase file can keep the quote, the payment receipt, the shipping confirmation, and the lot's COA when it was requested.
Frequently asked questions about Bronchogen
What is Bronchogen within the catalog's classification?
It is a short synthetic peptide in the peptide bioregulator family, grouped with Cardiogen, Cartalax, Cortagen, Crystagen, Pinealon and Vesugen.
What is the price of the 20 mg presentation?
The reference price is shown in this page's commercial block; that is always the figure that governs the quote.
Who issues Bronchogen's certificate of analysis?
Janoshik Analytical, per lot, with purity reported by HPLC and identity confirmed by mass spectrometry (MS). It is handled on request and subject to documentary availability.
How is this reference stored?
According to the documentation applicable to the lot. If it specifies 2–8 °C and protection from light, those conditions are built into the custody record before shipping.
How much does shipping cost?
Rates for Bogotá and for the rest of the country are shown on the site's shipping information. Time is confirmed at the time of quote. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.
How does Bronchogen differ from Cortagen?
Both are short peptides from the same bioregulator family, in a 20 mg presentation. The catalog distinguishes them by name and code, not by a published sequence; each one's identity is confirmed with its own lot's COA.
